TWC
ACET icon

TD Waterhouse Canada’s Adicet Bio ACET Stock Holding History

TD Waterhouse Canada’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26 Buy
+3
New +$24 ﹤0.01% 2367

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

TD Waterhouse Canada's ACET Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Adicet Bio (ACET) in Q2 2026: 3 shares worth $26. The stake represents ﹤0.01% of the portfolio and ranks #2367 among its holdings.

56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • TD Waterhouse Canada held 3 shares of Adicet Bio worth $26 as of Q2 2026.
  • Adicet Bio was a new TD Waterhouse Canada position in Q2 2026.
  • Adicet Bio made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2367 holding.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.